Skip to main content

XLVE.TO

ETF
—
—

Performance overview

XLVE.TO Price
Price Chart

Forward-looking statistics

Beta
0.19
Risk
33.33%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodActively Managed
DiversifiedNo
Expense ratio0.75%
Asset classUnknown

Top holdings

Us Dollar - London7.62%
Eli Lilly and Co4.20%
Us Dollar4.15%
UnitedHealth Group Inc3.85%
Johnson & Johnson3.60%
Universal Health Services Inc Class B1.71%
HCA Healthcare Inc1.58%
Intuitive Surgical Inc1.56%
Regeneron Pharmaceuticals Inc1.55%
Other70.16%

Sector exposure

Healthcare100.00%
Other0.00%

Country exposure

United States100.00%
Other0.00%

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeToronto Stock Exchange
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$64K
Avg trading volume (10 day)$49K
Put-call ratioN/A

Macro factor sensitivity

Growth-1.7
Credit+2.4
Liquidity-0.5
Inflation-1.7
Commodities-1.0
Interest Rates-1.3

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayJune 30, 2025

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free